| (210) | Number of the EPO application | 18740208 |
| (220) | Filing date of the EPO application | 2018.07.12 |
| (80) | EPO patent specification publication (B) | EPB nr. 35/2023, 2023.08.30 |
| (110) | EPO patent number | 3654983 |
| (21) | Number of the application | e 2020 0550 |
| (71) | Name(s) of applicant(s), code of the country | Astrazeneca AB, SE; |
| (72) | Name(s) of inventor(s), code of the country | WHITTAKER Andrew, GB;
SANGANEE Hitesh Jayantilal, GB; |
| (73) | Name(s) of owner(s), code of the country | ASTRAZENECA AB, SE; |
| (54) | Title of the invention | MPO INHIBITORS FOR USE IN MEDICINE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/505 (2006.01.01); A61P 15/10 (2006.01.01) |
| (19) | Country | SE |
| (41) | Date of publication of the application | 2020.06.30 |
| (30) | Priority | 201762533448 P, 2017.07.17, US |
| (86) | International application | PCT/EP2018/068992, 2018.07.12 |
| (87) | International publication | WO 2019/016074, 2019.01.24 |